- Trials with a EudraCT protocol (122)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (3)
122 result(s) found for: Doppler ultrasound.
Displaying page 1 of 7.
EudraCT Number: 2007-000467-23 | Sponsor Protocol Number: 1 | Start Date*: 2007-08-23 | ||||||||||||||||||||||||||
Sponsor Name:Erasmus MC | ||||||||||||||||||||||||||||
Full Title: Maternal and fetal haemodynamic response to Nifedipine tocolysis in normotensive pregnant women. | ||||||||||||||||||||||||||||
Medical condition: A more detailed investigation of the haemodynamic effect on the mother and fetus of Nifedipine tocolysis . Tocolysis will be used to facilitate external cephalic version for breech presentation at ... | ||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||
Population Age: In utero, Under 18, Adults | Gender: Male, Female | |||||||||||||||||||||||||||
Trial protocol: NL (Completed) | ||||||||||||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2007-000727-17 | Sponsor Protocol Number: 281274 | Start Date*: 2007-08-23 | ||||||||||||||||||||||||||||||||||||||||||||||
Sponsor Name:Erasmus MC | ||||||||||||||||||||||||||||||||||||||||||||||||
Full Title: Maternal, uteroplacental and fetal haemodynamic effect of Nicardipine in severe pre-eclampsia. | ||||||||||||||||||||||||||||||||||||||||||||||||
Medical condition: Hypertensive crisis in patients with severe pre-eclampsia needs to be treated to prevent maternal and fetal complications. The maternal, uteroplacental and fetal haemodynamic respose to antihypert... | ||||||||||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||||||||||
Population Age: Adults | Gender: Female | |||||||||||||||||||||||||||||||||||||||||||||||
Trial protocol: NL (Completed) | ||||||||||||||||||||||||||||||||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2020-000993-27 | Sponsor Protocol Number: 2019PI115 | Start Date*: 2020-07-16 | |||||||||||
Sponsor Name:CHRU NANCY | |||||||||||||
Full Title: AGATA: Value of contrast-enhanced ultrasound in adnexal torsion | |||||||||||||
Medical condition: Adnexal torsion | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Female | ||||||||||||
Trial protocol: FR (Prematurely Ended) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2013-002266-40 | Sponsor Protocol Number: CAIN457ADE02 | Start Date*: 2013-12-09 |
Sponsor Name:Novartis Pharma GmbH | ||
Full Title: A randomized, double-blind, placebo-controlled, multicenter, exploratory evaluation of surrogate markers of cardiovascular risk in patients with active chronic plaque-type psoriasis treated for 52 ... | ||
Medical condition: active chronic plaque-type psoriasis | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: DE (Completed) | ||
Trial results: View results |
EudraCT Number: 2016-000424-25 | Sponsor Protocol Number: 1508175 | Start Date*: 2016-04-12 | |||||||||||||||||||||
Sponsor Name:CHU Saint-Etienne | |||||||||||||||||||||||
Full Title: Low-molecular-weight heparin in constituted vascular intrauterine growth restriction. Randomized multicenter trial | |||||||||||||||||||||||
Medical condition: Intrauterine growth restriction (IUGR) | |||||||||||||||||||||||
|
|||||||||||||||||||||||
Population Age: Adults | Gender: Female | ||||||||||||||||||||||
Trial protocol: FR (Completed) | |||||||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2017-003425-15 | Sponsor Protocol Number: 2017 | Start Date*: 2017-11-10 | |||||||||||
Sponsor Name:Videncenter for Reumatologi og Rygsygdomme, Rigshospitalet | |||||||||||||
Full Title: Patients with rheumatoid arthritis and synovitis treated with ultrasound guided intraarticular or intramuscular glucocorticoid injection - A randomised, double-blind, controlled study (Panguian) | |||||||||||||
Medical condition: Treatment of synovitis among rheumatoid arthritis patients | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: DK (Trial now transitioned) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2012-002573-62 | Sponsor Protocol Number: ClinTrid-US-1201 | Start Date*: 2012-10-12 | |||||||||||
Sponsor Name:The Karolinska Institute, ClinTRID | |||||||||||||
Full Title: Doppler quantitative evaluation and follow-up over 12 months in RA patients with moderate and high disease activity who are candidates for biologic add-on therapy with Adalimumab | |||||||||||||
Medical condition: Rheumatoid arthritis (RA) | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: SE (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2018-002677-22 | Sponsor Protocol Number: TVECUSDoppler | Start Date*: 2020-02-05 |
Sponsor Name:Fundació Clínic per a la Recerca Biomèdica | ||
Full Title: Doppler sonography of skin and nodal metastases as a predictor of clinical response to Talimogene Laherparepvec (T-VEC) in melanoma patients (T-VEC – US Doppler) | ||
Medical condition: Melanoma stage IIIB-IVM1a | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: ES (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2011-001472-18 | Sponsor Protocol Number: UDT-2/PHT | Start Date*: 2011-05-10 |
Sponsor Name:STZ 1172 Gesundheitsförderung und Stoffwechselforschung | ||
Full Title: Double-Blind, Randomised, Cross-Over, Placebo-Controlled, Single-Centre Phase IIa Clinical Study on the Influence of Udenafil on the Portal Flow in Cirrhotic Patients with Portal Hypertension | ||
Medical condition: Portal hypertension, liver cirrhosis | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: DE (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2011-005979-16 | Sponsor Protocol Number: PrOvAS001 | Start Date*: 2013-04-29 |
Sponsor Name:Instituto de Investigación Sanitaria La Fe | ||
Full Title: PREECLAMPSIA OF PREVENTION IN PATIENTS THROUGH ovodonation aspirin in early gestation | ||
Medical condition: PREECLAMPSIA | ||
Disease: | ||
Population Age: Adults | Gender: Female | |
Trial protocol: ES (Prematurely Ended) | ||
Trial results: (No results available) |
EudraCT Number: 2008-002332-15 | Sponsor Protocol Number: D1840M00006 | Start Date*: 2008-09-15 |
Sponsor Name:AstraZeneca AB | ||
Full Title: A randomised, double-blind, placebo-controlled study to evaluate the transthoracic Doppler echocardiography method as a non-invasive method for coronary function measurements; ability to detect sho... | ||
Medical condition: In this study the IMP, rosuvastatin, is used as a tool compound for creating favourable lipid-altering, anti-inflammatory or other pleiotropic effects which are believed to change coronary flow res... | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: SE (Completed) | ||
Trial results: View results |
EudraCT Number: 2010-019688-12 | Sponsor Protocol Number: abchits2010 | Start Date*: 2010-10-18 | |||||||||||
Sponsor Name:Friedrich-Schiller University Jena, Clinic for Internal Medicine I | |||||||||||||
Full Title: Prospective placebo controlled trial: Detection of coronary microembolization by Doppler ultrasound in patients with stable angina pectoris during percutaneous coronary interventions under an adjun... | |||||||||||||
Medical condition: Up to 60 patients with stable angina pectoris and planned PCI at the University Clinic of Jena are randomly assigned to the glycoprotein IIb/IIIa receptor antagonist abciximab or placebo. Randomisa... | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2010-024528-12 | Sponsor Protocol Number: HGRWLBKULT1 | Start Date*: 2011-02-14 | |||||||||||
Sponsor Name:Henning Glerup | |||||||||||||
Full Title: Kontrast UltraLydsskanning af Tyndtarmen hos patienter med Crohns sygdom – et pilotstudie (KULT) | |||||||||||||
Medical condition: Morbus Crohn disease with signs of activity in the small bowel. | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DK (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2016-004396-51 | Sponsor Protocol Number: ZKS_0021PETN | Start Date*: 2017-06-26 | |||||||||||
Sponsor Name:Friedrich Schiller University | |||||||||||||
Full Title: Pentaerithrityl tetranitrate (PETN) for secondary prevention of intrauterine growth restriction (PETN Trial) | |||||||||||||
Medical condition: Pregnant women at risk of adverse pregnancy outcome due to intrauterine growth retardation identified by impaired uterine Doppler measurements at mid gestation (19+0 - 22+6 weeks of gestation). | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Female | ||||||||||||
Trial protocol: DE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2014-003469-10 | Sponsor Protocol Number: MUST14 | Start Date*: 2015-08-05 |
Sponsor Name:VU University Medical Center | ||
Full Title: The application of contrast-enhanced ultrasound to facilitate thrombolysis in patients with acute peripheral arterial occlusions. | ||
Medical condition: Acute peripheral arterial occlusions. Acute peripheral arterial occlusive disease can be caused by a blood clot blocking an artery in an arm or leg. This is an emergency situation that can result i... | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: NL (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2005-004209-27 | Sponsor Protocol Number: 05/Q1606/127 | Start Date*: 2005-11-11 |
Sponsor Name:Oxford Radcliffe Hospitals NHS Trust | ||
Full Title: Effect of altering inspired oxygen concentrations on cerebral oxygenation during awake carotid surgery | ||
Medical condition: Carotid endarterectomy is an operation performed on patients with a symptomatic stenosis of the internal carotid artery. Such patients have usually presented with stroke or transient ischaemic atta... | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: GB (GB - no longer in EU/EEA) | ||
Trial results: View results |
EudraCT Number: 2013-001492-20 | Sponsor Protocol Number: NN8226-4064 | Start Date*: 2014-02-12 | |||||||||||
Sponsor Name:Novo Nordisk A/S | |||||||||||||
Full Title: A randomised, active comparator, double-blind, multi centre, parallel, phase 2a trial, investigating the mechanism of action of NNC0109-0012 (anti-IL-20 mAb) through synovial biopsies in subjects w... | |||||||||||||
Medical condition: Rheumatoid arthritis | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IE (Prematurely Ended) GB (Prematurely Ended) ES (Prematurely Ended) PT (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2021-001399-40 | Sponsor Protocol Number: RECHMPL20_0092 | Start Date*: 2021-06-02 |
Sponsor Name:University hospital of Montpellier | ||
Full Title: Amlodipine interest in HRT (Hormone Replacement Therapy) cycle for frozen embryo transfer in the uterine pulsatility indices correction: double-blind randomized controlled trial | ||
Medical condition: uterine arteries pulsalility index for patients awaiting frozen embryo transfer | ||
Disease: | ||
Population Age: Adults | Gender: Female | |
Trial protocol: FR (Prematurely Ended) | ||
Trial results: (No results available) |
EudraCT Number: 2012-000622-22 | Sponsor Protocol Number: ASAP | Start Date*: 2012-07-20 | |||||||||||
Sponsor Name:Fundació Clínic per a la Recerca Biomèdica | |||||||||||||
Full Title: Aspirin for the enhancement of trophoblastic invasion in women with abnormal uterine artery Doppler at 11-14 weeks of gestation | |||||||||||||
Medical condition: Placental insufficiency | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Female | ||||||||||||
Trial protocol: ES (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2015-002161-27 | Sponsor Protocol Number: DUETII01 | Start Date*: 2016-04-15 |
Sponsor Name:Sint Antonius Hospital | ||
Full Title: Dutch randomized trial comparing Ultrasound-accElerated Thrombolysis with standard dose Urokinase versus half dose Urokinase for thrombo-embolic infra-inguinal arterial disease (DUET II) | ||
Medical condition: Acute thrombo-embolic occlusion of one of the infra-inguinal arteries | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: NL (Ongoing) | ||
Trial results: (No results available) |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here

Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
